Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: INTEGRATED DNA TECHNOLOGIES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-16 to 2024-09-30
Current total value of award: $23851.14
Description: CUSTOM SYNTHESIS OF 56 ANTISENSE OLIGONUCLEOTIDES (ASOS) FOR IN-VIVO LIVER TOX STUDY